chr2-159325797-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_013450.4(BAZ2B):c.6065C>A(p.Thr2022Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000267 in 1,609,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 0 hom. )
Consequence
BAZ2B
NM_013450.4 missense
NM_013450.4 missense
Scores
1
5
13
Clinical Significance
Conservation
PhyloP100: 7.01
Genes affected
BAZ2B (HGNC:963): (bromodomain adjacent to zinc finger domain 2B) This gene belongs to the bromodomain gene family. Members of this gene family encode proteins that are integral components of chromatin remodeling complexes. The encoded protein showed strong preference for the activating H3K14Ac mark in a histone peptide screen, suggesting a potential role in transcriptional activation. This gene may be associated with susceptibility to sudden cardiac death (SCD). [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.21423832).
BP6
Variant 2-159325797-G-T is Benign according to our data. Variant chr2-159325797-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 2352050.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BAZ2B | NM_013450.4 | c.6065C>A | p.Thr2022Lys | missense_variant | 35/37 | ENST00000392783.7 | NP_038478.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BAZ2B | ENST00000392783.7 | c.6065C>A | p.Thr2022Lys | missense_variant | 35/37 | 5 | NM_013450.4 | ENSP00000376534.2 | ||
BAZ2B | ENST00000392782.5 | c.5957C>A | p.Thr1986Lys | missense_variant | 34/36 | 1 | ENSP00000376533.1 | |||
BAZ2B | ENST00000474437.1 | n.605C>A | non_coding_transcript_exon_variant | 4/4 | 3 | |||||
BAZ2B | ENST00000548440.1 | n.579C>A | non_coding_transcript_exon_variant | 2/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151914Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
151914
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000326 AC: 8AN: 245464Hom.: 0 AF XY: 0.0000376 AC XY: 5AN XY: 133062
GnomAD3 exomes
AF:
AC:
8
AN:
245464
Hom.:
AF XY:
AC XY:
5
AN XY:
133062
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000268 AC: 39AN: 1457086Hom.: 0 Cov.: 32 AF XY: 0.0000331 AC XY: 24AN XY: 724506
GnomAD4 exome
AF:
AC:
39
AN:
1457086
Hom.:
Cov.:
32
AF XY:
AC XY:
24
AN XY:
724506
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151914Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74196
GnomAD4 genome
AF:
AC:
4
AN:
151914
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74196
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Uncertain
D;D
Polyphen
P;D
Vest4
MutPred
0.29
.;Gain of ubiquitination at T2022 (P = 0.0051);
MVP
MPC
0.19
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at